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a b s t r a c t
Introduction: Symptoms of COVID-19 vary in severity and presentation. When admitting patients to the hospital,
it is desirable to isolate patients with COVID-19 from those without the disease. However, reliably identifying patients with COVID-19 in the emergency department before hospital admission is often limited by the speed and
availability of testing. Previous studies determined a low lymphocyte count is commonly found in patients with
COVID-19. We sought to explore the sensitivity of absolute lymphocyte count in patients presenting to the emergency department requiring subsequent hospitalization who were found to have COVID-19.
Methods: A retrospective chart review was performed on 312 patients with laboratory-conﬁrmed COVID-19 who
were admitted to the hospital from the emergency department. The absolute lymphocyte count for these patients
was used to calculate sensitivities at various cut-off values. The relationships between absolute lymphocyte count
and variables, including age, sex, need for intubation, and mortality, were also explored.
Results: Cut-off values for absolute lymphocyte count ranged from 1.1 K/uL to 2.0 K/uL, with sensitivities of 72%
and 94%, respectively. Additionally, lower mean absolute lymphocyte counts were identiﬁed in males, patients
who required intubation, and patients who died.
Conclusion: Knowing the sensitivity of absolute lymphocyte count in patients with COVID-19 may help identify
patients who are unlikely to have the disease. Additionally, absolute lymphocyte count can be used as a marker
of disease severity in patients with COVID-19.
© 2021 Elsevier Inc. All rights reserved.

1. Introduction
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a
novel virus that causes coronavirus disease (COVID-19) [1]. Symptoms
of COVID-19 vary in severity and presentation, and many patients
with COVID-19 may be asymptomatic or have only mild symptoms
[2]. When admitting patients to the hospital, it is desirable to isolate patients with COVID-19 from those without the disease. However, reliably
identifying patients with COVID-19 in the emergency department (ED)
before hospital admission is often limited by the speed and availability
of SARS-CoV-2 testing.
Current research suggests that lymphopenia, deﬁned as a low lymphocyte count, is commonly present in patients with COVID-19 [3,4].

There is also evidence that the degree of lymphopenia correlates with
illness severity in patients with COVID-19 [5-7]. The converse may
also be true; those without lymphopenia may be unlikely to have
COVID-19, but currently, there is a paucity of data to support this.
Turn-around-time for absolute lymphocyte count (ALC) is much
quicker than SARS-CoV-2 testing, with results obtained while the
patient is in the ED. We explore the relationship between lymphopenia and COVID-19 in patients who present to the ED and require
hospitalization.

2. Methods
2.1. Design

Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; COVID19, coronavirus disease; ED, emergency department; ALC, absolute lymphocyte count; RTPCR, reverse transcription-polymerase chain reaction; CBC, complete blood count; WBC,
white blood count; CDC, Centers for Disease Control and Prevention; AGPs, aerosolgenerating procedures.
⁎ Corresponding author at: Henry Ford Wyandotte Hospital, Department of Emergency
Medicine, 2333 Biddle Avenue, Wyandotte, MI 48192, USA.
E-mail address: zillg1@hfhs.org (Z. Illg).
1
Present address: Department of Anesthesiology, Division of Critical Care, University of
California, San Diego, San Diego, CA, USA.

A retrospective chart review was performed to assess the relationship between ALC and infection from SARS-CoV-2 in patients with
laboratory-conﬁrmed COVID-19 who were admitted to the hospital
from the ED. We hypothesized that in patients presenting to the ED requiring subsequent hospitalization, ALC cut-off values could be used to
help physicians identify patients who are unlikely to have COVID-19.
ALC and secondary variables, including age, sex, need for intubation (either in the ED or during hospitalization), and mortality, were of interest
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Sample testing for SARS-CoV-2 was similarly acquired by an ED
nurse or physician during a patient's ED encounter using a nasal or nasopharyngeal swab. Samples obtained from March 15, 2020, through
March 26, 2020, were analyzed using the Centers for Disease Control
and Prevention (CDC) RT-PCR assay on a Roche LC480 thermocycler at
Henry Ford Hospital in Detroit, Michigan. From March 27, 2020, through
the end of the study period, the RT-PCR assay was analyzed on a
NeumoDx, Diasorin Simplexa, or Cephelid GenXpert automated RTPCR platform. The results from all samples were expressed as either positive or negative. A positive result was deﬁned by the expression of one
of two genetic targets on the SARS-CoV-2 genome in quantity greater
than the predetermined ﬂuorescence threshold.

to the authors. The need for intubation and death were used to qualify
disease severity.
The study received approval by the authors' Institutional Review
Board before data collection or analysis. The authors performed all
data abstraction, and an initial meeting was held between authors to ensure consistent and accurate data collection methods and documentation. Additional meetings were held as-needed to resolve any
questions regarding data collection.
2.2. Setting
This study took place at Henry Ford Wyandotte Hospital (HFWH), a
360-bed community-based teaching hospital located in the Detroit Metropolitan area whose ED receives approximately 60,000 visits a year.

2.5. Data analysis

2.3. Sample

The primary outcome of interest was the ALC of patients who required hospitalization during our study period, as we hypothesized
that ALC could be used to help physicians identify patients who are unlikely to have COVID-19. The secondary outcome of interest was the relationship, if any, between ALC and disease severity in patients who
required hospitalization. ALC was compared for all variables using
Kruskal-Wallis tests with mean, standard deviation, median, and interquartile range presented. Pearson's correlation coefﬁcient was computed to assess the association between age and ALC. The need for
intubation and death were used to qualify disease severity. Sensitivity
and the corresponding 95% conﬁdence intervals were determined at different cut-off values.
In addition to assessing ALC as a continuous measure, patients were
divided into groups based on the normal range for ALC (1.10–4.00 K/
uL). There were two patients with an ALC above the normal range;
therefore, patients in the normal range and above normal range were
grouped. All variables were compared between the normal/above normal ALC values and the below normal ALC values using t-tests for age
and chi-square tests for categorical covariates. For categorical variables,
the number and percentages were presented. For quantitative variables,
the mean and standard deviation were presented. The testing level for

The sample population consisted of adult patients who presented to
the HFWH ED between March 20, 2020, and May 5, 2020, required
hospital admission and had a positive SARS-CoV-2 reverse transcriptionpolymerase chain reaction (RT-PCR) result. A positive SARS-CoV-2 RTPCR result was found either in the ED or during hospitalization. Inclusion
criteria included patients aged ≥18 years, hospital admission, COVID-19
as conﬁrmed by SARS-CoV-2 RT-PCR, and a complete blood count (CBC)
with ALC obtained in the ED or during hospitalization. Exclusion criteria
included patients aged <18 years, discharged from the ED, negative
SARS-CoV-2 RT-PCR testing, and no ALC obtained during ED encounter
or hospitalization duration. A total of 312 patients were eligible for inclusion in our study based on inclusion criteria. One patient was excluded
from data analysis due to a pre-existing diagnosis of chronic lymphocytic
leukemia with an ALC of 72.16 K/uL. As such, 311 patients were included
for data analysis.
2.4. Data Collection & Measurement
Blood samples for laboratory evaluation were collected at the
patient's bedside by ED nurses or physicians while in the ED. Only
data from the ﬁrst blood draw that included ALC was included in our
analysis. All patients in our study had a CBC with ALC drawn in the
ED; thus, no blood samples acquired upon hospitalization were used
in our analysis. CBC samples were assessed by the HFWH laboratory
on a UniCel DxH 800 Coulter Cellular Analysis System. The white
blood cell (WBC) count was derived using the Coulter Principle. The
ALC was then derived from the sample's calculated lymphocyte percentage and WBC count and was expressed in microliters (uL).

Table 2
ALC sensitivity at cutoff values
ALC cutoff

Sensitivity 95% lower conﬁdence limit 95% upper conﬁdence limit

1.1 (K/uL)
1.25 (K/uL)
1.5 (K/uL)
2.0 (K/uL)

72%
78%
85%
94%

67%
73%
81%
91%

77%
82%
89%
96%

Table 1
Comparing absolute lymphocyte count
Variable

Level

Sex

Female
Male
No
Yes
No
Yes
Death with Intubation
Death without Intubation
Intubation without death
Neither death or intubation
<50
50–59
60–69
70–79
80+

Intubated
Died
Severity

Age group

Absolute lymphocyte count (K/uL)
N

Mean (SD)

Median (IQR)

Kruskal-Wallis P-value

164
147
228
83
226
85
51
34
32
194
47
49
70
59
86

1.06 (0.71)
0.90 (0.62)
1.01 (0.66)
0.91 (0.72)
1.01 (0.66)
0.91 (0.72)
0.96 (0.83)
0.85 (0.51)
0.83 (0.50)
1.04 (0.67)
1.08 (0.63)
0.92 (0.50)
0.89 (0.67)
0.90 (0.53)
1.11 (0.84)

0.80 (0.6, 1.3)
0.80 (0.5, 1.1)
0.80 (0.6, 1.2)
0.80 (0.4, 1.1)
0.80 (0.6, 1.2)
0.76 (0.5, 1.02)
0.76 (0.4, 1.1)
0.75 (0.5, 1.0)
0.80 (0.5, 1.1)
0.80 (0.6, 1.3)
1.00 (0.7, 1.3)
0.80 (0.5, 1.2)
0.70 (0.5, 1.0)
0.80 (0.5, 1.3)
0.80 (0.6, 1.2)

0.041
0.048
0.047
0.093

0.145
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Table 3
Comparing grouped absolute lympocyte count
Covariate

Statistics

Level

Below normal ALC N = 210

Normal/above normal ALC N = 101

P-valuea

Sex

N (Col %)
N (Col %)
N
Mean (SD)
N (Col %)
N (Col %)
N (Col %)
N (Col %)
N (Col %)
N (Col %)
N (Col %)
N (Col %)

Female
Male

105 (50)
105 (50)
210
68.08 (15.86)
150 (71.43)
60 (28.57)
146 (69.52)
64 (30.48)
38 (18.1)
26 (12.38)
22 (10.48)
124 (59.05)

59 (58.42)
42 (41.58)
101
64.99 (18.71)
78 (77.23)
23 (22.77)
80 (79.21)
21 (20.79)
13 (12.87)
8 (7.92)
10 (9.9)
70 (69.31)

0.164

Age
Intubated
Died
Severity

a

No
Yes
No
Yes
Death with Intubation
Death without Intubation
Intubation without Death
Neither Death or Intubation

0.131
0.279
0.073
0.315

The p-value is calculated by t-test for age and chi-square test for categorical covariates.

performed in the ED include non-invasive positive pressure ventilation,
endotracheal intubation, airway suctioning, high-ﬂow oxygen delivery,
and nebulized medication administration. Knowing the sensitivity of
ALC in patients with COVID-19 may help physicians identify patients
who are unlikely to have the disease, allowing patients who beneﬁt
from AGPs to receive timely treatment in the ED without exposing
nurses, physicians, and respiratory therapists to infectious pathogens.
Furthermore, expeditious cohorting of patients unlikely to have
COVID-19 allows for the early removal of isolation precautions, reducing hospital costs and resource utilization through diminished personal
protective equipment use.
Our data also demonstrates the degree of lymphopenia correlates
with COVID-19 severity, speciﬁcally, the need for intubation and
death. As such, ALC may serve as a prognostic indicator in patients
with COVID-19, allowing physicians to pursue more aggressive treatment regimens in patients at risk for severe disease.

all comparisons was 0.05. All analyses were performed using SAS 9.4
(SAS Institute Inc., Cary, NC, USA).
3. Results
A total of 311 patients with COVID-19, as conﬁrmed by SARS-CoV-2
RT-PCR, were included in the data analysis. Patient ages ranged from 18
to 97 years, with the mean age being 67.1 years (SD = 16.9). Breakdown of the variables analyzed were as follows: 147 (47.3%)
patients were male, 83 (26.7%) patients were intubated, 85 (27.3%) patients died, 51 (16.4%) patients died while intubated, 34 (10.9%) patients died without intubation, 32 (10.3%) patients required intubation
and survived, and 194 (62.4%) patients survived without intubation.
Additionally, 2 (0.6%) patients had ALC values above the normal
range, 99 (31.8%) patients had ALC values within the normal range,
and 210 (67.5%) patients had ALC values below the normal range. The
normal range used for ALC was 1.10–4.00 K/uL, as this was the range
used by the HFWH laboratory for reporting normal versus abnormal results. The mean ALC of patients in our study was 0.99 K/uL (SD = 0.67),
while the median ALC was 0.80 K/uL (IQR = 0.6,1.2).
ALC values were compared among the various subgroups analyzed
(Table 1). Male patients had a lower ALC than female patients, with
means of 0.90 K/uL and 1.06 K/uL, respectively (p = 0.041). Patients
who required intubation had a lower ALC (0.91 K/uL) than those who
did not (1.01 K/uL) (p = 0.048). Patients who died had a lower ALC
(0.91 K/uL) than those who survived (1.01 K/uL) (p = 0.047). The
correlation between age and ALC was not statistically signiﬁcant
(p = 0.850). There were no signiﬁcant differences in ALC based on the
combination of intubations and death (p = 0.093) and age groups
(p = 0.145).
The sensitivity of ALC in our patient population was assessed using
different cut-off values, as outlined in Table 2. Cut-off values ranged
from 1.1 K/uL to 2.0 K/uL, with sensitivities of 72% and 94%, respectively.
Lastly, no signiﬁcant differences were appreciated between the
below normal ALC group and the normal/above normal ALC group for
any of the variables in Table 3, including sex, age, need for intubation,
or death.

4.1. Limitations
All patients requiring admission to HFWH during the study dates
underwent SARS-CoV-2 RT-PCR testing, regardless of symptoms or reason for hospital admission. Cases of a positive SARS-CoV-2 RT-PCR result
after resolution of COVID-19 have been reported [9]. As such, patients
included in our study might have had a positive SARS-CoV-2 RT-PCR
without active COVID-19 and required admission for an alternate
reason (i.e., acute surgical issue), resulting in the inclusion of patients
without active COVID-19 in our study.
Our study only included patients who required hospital admission. It
did not include patients who were discharged from the ED with conﬁrmed or suspected COVID-19. As such, further studies should be conducted to determine if the ALC cut-off values found in our study
extend to this population.
There are a multitude of variables and disease processes that lead to
lymphopenia. These include bacterial and fungal sepsis, corticosteroid
use, chemotherapy and radiation therapy, and trauma [10]. Patients in
our study may have had factors independent of COVID-19 that contributed to a decreased ALC.
Our study was designed to assess the sensitivity of ALC in patients
with COVID-19. As such, only patients with COVID-19 were included
in our study. Additional studies are needed to determine the speciﬁcity and positive and negative predictive values of ALC as it relates
to COVID-19.

4. Discussion
Availability and turn-around-time for SARS-CoV-2 PCR testing remain the rate-limiting step in diagnosing COVID-19 in many hospitals
and health systems. Our study identiﬁed ALC cut-off values with corresponding sensitivities that may be used as a surrogate marker to help
identify patients who are unlikely to have COVID-19 upon hospital admission and allow for rapid cohorting of patients.
Current CDC recommendations advise, if possible, avoiding aerosolgenerating procedures (AGPs) in patients with COVID-19 as these procedures may increase the risk of viral transmission [8]. AGPs commonly

5. Conclusion
Knowing the sensitivity of ALC in patients with COVID-19 may help
identify patients who are unlikely to have the disease upon hospital admission, allowing for rapid cohorting of patients and safe utilization of
18
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